The 2020 update of the Canadian Stroke Best Practice Recommendations (CSBPR) for the
Secondary Prevention of Stroke includes current evidence-based recommendations and …

Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is
often more severe and disabling than the index event. Optimum secondary prevention of …

Background Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke
as compared with aspirin alone when treatment is initiated early (≤ 24 hours) after an acute …

AR Naylor a, J.-B. Ricco a, GJ de Borst a, S. Debus a, J. de Haro a, A. Halliday a, G.
Hamilton a, J. Kakisis a, S. Kakkos a, S. Lepidi a, HS Markus a, DJ McCabe a, J. Roy a, H …

The management of extracranial cerebrovascular disease, including carotid endarterectomy
(CEA), carotid stenting and medical management is performed by several specialists …

The 2017 update of The Canadian Stroke Best Practice Recommendations for the
Secondary Prevention of Stroke is a collection of current evidence-based recommendations …

Background Intensive antiplatelet therapy with three agents might be more effective than
guideline treatment for preventing recurrent events in patients with acute cerebral …

Objective To assess the effectiveness and safety of dual agent antiplatelet therapy
combining clopidogrel and aspirin to prevent recurrent thrombotic and bleeding events …

Objective: We aimed to investigate whether the efficacy and safety of clopidogrel plus aspirin
vs aspirin alone were consistent between patients with and without intracranial arterial …

Background and Purpose—We assessed whether lower-dose alteplase at 0.6 mg/kg is
efficacious and safe for acute fluid-attenuated inversion recovery-negative stroke with …